Author Summary
WFDC3: Novel Prognostic Biomarker in Pancreatic Cancer
Introduction: The Challenge of Pancreatic Cancer Pancreatic ductal adenocarcinoma (PAAD) remains one of the deadliest cancers, with a five-year survival rate near 10%. Its silent onset, rapid spread, and resistance to current treatments make early […]